Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-041546
Filing Date
2025-03-18
Accepted
2025-03-18 18:35:25
Documents
1
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11589
  Complete submission text file 0000950170-25-041546.txt   13017
Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 203 CRESCENT STREET, BLDG. 17, SUITE 102 WALTHAM MA 02453
Business Address
Meisner Lara (Reporting) CIK: 0001883986 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 25750148

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)